KLRA
Kailera Therapeutics, Inc.
Set alert
12.86 USD -0.55 -4.10%
12.54 Day range 13.40
10.00 52-week range 26.00
- YTD
- -50.54%
- 1 year
- -50.54%
- Open
- 13.27
- Prev close
- 13.41
- Mkt cap
- 1.67B
- Vol
- 868.43K
- Avg vol
- 1.02M
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.54
- High
- 13.40
- Forward P/E
- -2.99
- Beta
- 0.00
- Short ratio
- 5.58
- Inst. own
- 90.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 13.39
- 200-d avg
- 18.01
- 1y target
- 42.75
Ownership
Held by insiders 8.91%
Held by institutions 90.55%
Float held by institutions 99.40%
Institutions 156
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Investors Llc | 20.25% | 26,255,581 | 337.65M | Jun 29, 2026 |
| Bain Capital Life Sciences Investors, LLC | 17.42% | 22,583,268 | 290.42M | Jun 29, 2026 |
| RTW Investments LP | 8.31% | 10,776,820 | 138.59M | Jun 29, 2026 |
| Canada Pension Plan Investment Board | 5.63% | 7,304,688 | 93.94M | Jun 29, 2026 |
| Atlas Venture Life Science Advisors, LLC | 3.99% | 5,171,282 | 66.50M | Jun 29, 2026 |
| FMR, LLC | 3.06% | 3,970,865 | 51.07M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.69% | 2,191,928 | 28.19M | Jul 30, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 0.94% | 1,221,869 | 15.71M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.93% | 1,199,783 | 15.43M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.91% | 1,180,411 | 15.18M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.70% | 904,283 | 11.63M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 0.66% | 850,042 | 10.93M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAIN CAPITAL INVESTORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 19, 2026 | 2,034,130 |
| KAPLAN ANDREW T | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| KOPPEL ADAM M | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| RENAUD RONALD C JR | Chief Executive Officer | Conversion of Exercise of derivative security | Jun 8, 2026 | 38,094 |
Held by funds
70 US ETFs and mutual funds hold KLRA · largest positions